RB Global Other Non-Current Liabilities decreased by 0.1% to $158.30M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 52.9%, from $103.50M to $158.30M. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows relatively stable performance with a 0.7% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $156.64M | $153.56M | $147.26M | $150.11M | $155.91M | $137.23M | $35.40M | $59.30M | $56.30M | $70.80M | $86.70M | $85.10M | $87.60M | $90.60M | $97.40M | $103.50M | $128.70M | $171.80M | $158.50M | $158.30M |
| QoQ Change | — | -2.0% | -4.1% | +1.9% | +3.9% | -12.0% | -74.2% | +67.5% | -5.1% | +25.8% | +22.5% | -1.8% | +2.9% | +3.4% | +7.5% | +6.3% | +24.3% | +33.5% | -7.7% | -0.1% |
| YoY Change | — | — | — | — | -0.5% | -10.6% | -76.0% | -60.5% | -63.9% | -48.4% | +144.9% | +43.5% | +55.6% | +28.0% | +12.3% | +21.6% | +46.9% | +89.6% | +62.7% | +52.9% |